Cookie-Einstellungen
     
 
 
开放获取期刊 返回
快速、高质量地传播跨主要科学与工程学科的药物研发的最新突破。

Issues per year : 4
Volume : 4
Year : 2022
ISSN : 2628-5096

该刊可在Thieme E-Journals平台免费阅读。

5d14bb599afee.png 

Pharmaceutical Fronts上发表论文,作者可享:

    · 2022-2023年免除论文处理费(Article Processing Charge)

    · 公平、建设性和及时的同行评议

    · 初次投稿时,作者可以自由选择论文格式投稿

    · 快速发表(初审2-3周;最终录用7-8周)

    · 有机会获得“优秀论文奖(Outstanding Article Award)”及证书

    · 最大限度地提高作者贡献和研究团队的可见性

Pharmaceutical Fronts为基于开放获取模式的国际同行评审期刊,出版与药物研发相关的所有科学和工程学科最新突破的原创研究。Pharmaceutical Fronts 是《中国医药工业杂志》(Chinese Journal of Pharmaceuticalswww.cjph.com.cn)的附属期刊 (EI核心期刊),《中国医药工业杂志》创刊于1970年,由上海医药工业研究院、中国药学会、中国化学制药工业协会主办。本刊现已位居中国医药科学全部期刊榜首。

本刊与中国医药工业研究总院(China State Institute of Pharmaceutical Industry)和中国医药工业信息中心(China National Pharmaceutical Industry Information Center)密切相关。中国医药工业研究总院是中国医药集团有限公司的子公司(国药控股),国务院国资委直属大型医疗集团,在我国医药研究中处于领先地位。中国医药工业信息中心成立于1958年,以其领先的研发能力为国有和私营公司提供服务。中国医药工业信息中心还为相关领域专家的学术交流提供了一个独一无二的平台。

Pharmaceutical Fronts通过创新性的稿件获取和审阅过程,以信息密度,可靠性和实用性为重点,为读者带来极佳体验。本刊强调促进制药行业安全、环境友好和经济制造的“制药过程”。Pharmaceutical Fronts还报告了与工业应用相关的前沿科学发展,涵盖了实验和生产环境下药物化学、工艺开发和技术创新方面的广泛原始报告。它为全球科学和工业界提供了一个高级论坛,以寻求更好的药品和在工业规模下制备此类药品治疗疾病的更好方法。

每年出版4期,Pharmaceutical Fronts涵盖以下领域的重要原创研究论文以及高质量的综述、评论和简讯:

    · 化学药物与合成技术

    · 不对称催化与绿色化学

    · 药物化学

    · 微生物药物和生物制药

    · 药物科学与制剂技术

    · 分析科学

    · 工程创新

    · 工艺安全与法规科学

稿件的接受是基于原创性、在医药行业领域的重要性、科学严谨性和呈现的清晰度。Pharmaceutical Fronts 要求作者遵循 ICMJE(国际医学期刊编辑委员会)对医学期刊学术著作的撰写、报告、编辑和出版方面的建议。更多信息请见:http://www.icmje.org

如果作者对自己的研究是否属于期刊的征稿范围有疑问,请在投稿前与主编联系。请通过电子邮件将摘要或详细总结发送至 Pharmaceutical Fronts 编辑部:Zhangll_ea_pharm@126.com  或   zhangll@pharmadl.com.

Click here for the journal's Ethic Statement.

5d0de93cc580d.png

开放获取版权
所有
Pharmaceutical Fronts论文均根据知识共享许可 CC BY(署名)出版。Pharmaceutical Fronts发表的论文是完全开放获取的:可立即免费阅读、下载和共享。论文处理费(APC)可能在2023年以后适用。

索引库: DOAJ, EBSCO, ProQuest



编辑委员会
×

Editorial Board

Pharmaceutical Fronts

Editor-in-Chief

Fen-Er CHEN, Fudan University, Department of Chemistry, Shanghai, China
rfchen@fudan.edu.cn

Associate Editors

Qin HE, West China School of Pharmacy, Sichuan University Chengdu, China
qinhe317@126.com

Bu-Yong MA, Shanghai Jiao Tong University, Shanghai, China
mabuyong@sjtu.edu.cn

Xun SUN, West China School of Pharmacy, Sichuan University, Chengdu, China
sunxun@scu.edu.cn

Ji-Ming WANG, Center for Cancer Research, National Cancer Institute, Maryland, USA
wangji@mail.nih.gov

Jian-Xin WANG, School of Pharmacy, Fudan University, Shanghai, China
jxwang@shmu.edu.cn

Ji ZHANG, HEC Pharm Group, HEC R&D Center, Dongguan, China
ZhangJi@hecpharm.com

Xu-Mu ZHANG,Southern University of Science and Technology, Shenzhen, China
zhangxm@sustech.edu.cn

Tony ZHANG, Tyligand Bioscience (Shanghai) Limited, Shanghai, China
Tony@tyligand.com

Jian-Wei ZHU, Shanghai Jiao Tong University, Shanghai, China
jianweiz@sjtu.edu.cn

Editorial Board

James P. COLLMAN, Department of Chemistry, Stanford University, Stanford, California, US
jpc@stanford.edu

Lei FU, Shanghai Jiao Tong University, Shanghai, China
leifu@sjtu.edu.cn

Andrea GAZZANIGA, Pharmaceutical Technology & Regulatory Affairs "M. E. Sangalli" Unit, Milano, Italy
andrea.gazzaniga@unimi.it

PING I. LEE, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
ping.lee@utoronto.ca

Hong-Lin LI, East China University of Science and Technology, Shanghai, China
hlli@ecust.edu.cn

Gary LI, ALSTEM LLC, Richmond, USA
gli@alstembio.com


Xiaoling LI, Thomas J Long School of Pharmacy, University of the Pacific, Stockton, USA
xli@pacific.edu

Hong LIU, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
hliu@simm.ac.cn

Wei-Gen LU, China State Institute of Pharmaceutical Industry, Shanghai, China
sipiluwg@163.com

You-Fu LUO, West China Medical School, Sichuan University, Chengdu, China
luo_youfu@scu.edu.cn

Andrew D. Miller, King's College London, London, UK
miller@vri.cz

Xiong-Wei NI, School of Engineering & Physical Sciences, Heriot-Watt University, Riccarton, UK
x.ni@hw.ac.uk

Hong-Jun REN, Taizhou University, TaiZhou, China
renhj@tzc.edu.cn


Wei-Ke SU, Zhejiang University of Technology, Hangzhou, China
suweike@zjut.edu.cn

Peter SWAAN, School of Pharmacy, University of Maryland, Maryland, US
pswaan@rx.umaryland.edu


Hao WANG, National Pharmaceutical Engineering Research Center, Shanghai, China
wanghao@sphchina.com

Shu-Yuan WEI, China State Institute of Pharmaceutical Industry, Shanghai, China
sywei1102@yahoo.com.cn

Bin YU, Zhengzhou University, Zhengzhou, China
zzuyubin@hotmail.com


Jonathan ZHANG, Santa Clara University, Santa Clara, US
zzhang@scu.edu

Wan-Bin ZHANG, Shanghai Jiao Tong University, Shanghai, China
wanbin@sjtu.edu.cn

Yi-Xuan ZHANG, Shenyang Pharmaceutical University, Shenyang, China
zhangyxzsh@163.com


Youth Editorial Board

Liang OU-YANG, West China Hospital of Sichuan University, Chengdu, China
ouyangliang@scu.edu.cn


Bin QIN, Shenyang Pharmaceutical University, Shenyang, China
to-qinbin@163.com


Xiao XIAO, Zhejiang University of Technology, Hangzhou, China
Zhangll_ea_pharm@126.com


EDITORIAL CONTACTS

Please contact the Editors or Thieme Publishers with any questions.

Editorial Office
Lili Zhang
1320 Beijing Xi Lu,
JingAn District,
Shanghai 200040, P.R. China
Tel: +86 21 6279 3151
Email: 20073600lili@sina.com

Thieme Publishers – Medical Journals Acquisitions Editor Sharon Huang
Thieme Publishers
Rm 2162, Sunflower Tower, 37 Maizidian Str.,ChaoYang District,
Beijing 100088 P.R. China
Tel: +86 10 9595 0626
Email: sharon.huang@thieme.com


Close
出版费用
×

2022 Article Publication Charges

Pharmaceutical Fronts





CC BY-NC-ND

CC-BY


Euro (€)

US Dollar ($)

Euro (€)

US Dollar ($)

Article

free*

free*

free*

free*





APC payments are due upon acceptance of the manuscript 

*society funded


Close